| Brenda Sambrano Cataylo, REGISTERED NURSE | |
|
100 Melrose Ave Ste 206, Greenwich, CT 06830-6277 | |
| (347) 578-0196 | |
| Not Available |
| Full Name | Brenda Sambrano Cataylo |
|---|---|
| Gender | Female |
| Speciality | Registered Nurse - Home Health |
| Location | 100 Melrose Ave Ste 206, Greenwich, Connecticut |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1134985336 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 163WH0200X | Registered Nurse - Home Health | 081587 (Connecticut) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Brenda Sambrano Cataylo, REGISTERED NURSE 59 Liberty St Apt 12, Stamford, CT 06902-4720 Ph: (203) 252-6653 | Brenda Sambrano Cataylo, REGISTERED NURSE 100 Melrose Ave Ste 206, Greenwich, CT 06830-6277 Ph: (347) 578-0196 |
News Archive
In the study, the scientists screened known drugs and identified small molecules that could replace conventional reprogramming genes, which can have dangerous side effects.
GENTAG, Inc., Third Technology Capital Investors, and The CORE Institute are pleased to announce the first fully integrated medical grade wireless monitoring kit for post-surgery applications compatible with the new generation of Near Field Communications (NFC) cell phones. The kit allows patients to self-monitor for excessive swelling in the surgery area or inside casts with their cell phones after hospital discharge (compartment syndrome monitoring).
A new five-year, $6.25 million grant from the National Institutes of Health will help investigators from Northwestern University, the University of Chicago and others across the city of Chicago work together to slow and stop HIV.
Cardiva Medical, Inc. today announced that the U.S. Food and Drug Administration (FDA) has granted Premarket Approval (PMA) for the VASCADE Vascular Closure System (VCS).
Implicit Bioscience has announced that it has been awarded a US$16.34 million (AU$18.2million) contract payable over 37 months from the United States Defense Threat Reduction Agency (DTRA) to develop its clinical stage drug oglufanide disodium as a broad spectrum therapeutic for the treatment of a number of intracellularbacterial diseases.
› Verified 5 days ago
Jaclyn Suzanne Porco, Registered Nurse Medicare: Accepting Medicare Assignments Practice Location: 5 Perryridge Rd, Greenwich, CT 06830 Phone: 212-746-2959 | |
Kristen B Burleson, RN Registered Nurse Medicare: Not Enrolled in Medicare Practice Location: 1391 King St, Greenwich, CT 06831 Phone: 203-246-8411 | |
Ms. Cassandra Krizia Mae Lumucso Zapanta, Registered Nurse Medicare: Not Enrolled in Medicare Practice Location: 100 Melrose Ave Ste 206, Greenwich, CT 06830 Phone: 860-897-6235 | |
Melissa Giraldez, RN Registered Nurse Medicare: Not Enrolled in Medicare Practice Location: 5 Perryridge Rd, Greenwich, CT 06830 Phone: 203-863-3510 | |
Sandra Morano, Registered Nurse Medicare: Not Enrolled in Medicare Practice Location: 78 Bruce Park Ave, Greenwich, CT 06830 Phone: 203-391-8821 | |
Brid Osullivan, RN Registered Nurse Medicare: Not Enrolled in Medicare Practice Location: 100 Melrose Ave Ste 206, Greenwich, CT 06830 Phone: 212-532-7620 |